Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KOREA UNITED PHARM. INC.

Home Clinical Trial Sponsors and OrganizationsKOREA UNITED PHARM. INC.

KOREA UNITED PHARM. INC.

25-23 Nojanggongdan-gil, Jeondong-myeon, Sejong, South Korea

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

24

4 active

Approvals

63

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

18

75.0%

Phase 3

3

12.5%

Phase 4

2

8.3%

Phase 2

1

4.2%

Trial Status Distribution

Completed

13

54.2%

Not yet recruiting

4

16.7%

Recruiting

2

8.3%

Terminated

1

4.2%

Unknown

4

16.7%

Clinical Trials

Trials sponsored by this organization (24)

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Jul 202636 participants

Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers

Not yet recruiting

Jul 202660 participants

A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions

Not yet recruiting

Apr 202644 participants

A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers

Aug 202550 participants

Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions

Feb 202544 participants

Bioequivalence Study Between UI009 and UIC202005 in Healthy Subjects

Oct 202430 participants

A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201

Not yet recruiting

Jul 202466 participants

A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

Oct 20238 participants

Page 1 of 3

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

53

Approvals

NPRA

National Pharmaceutical Regulatory Agency

10

Approvals

Recent Approvals

PURINETONE TABLETS MERCAPTOPURINE 50MG

Pemirex powder for concentrate for solution for infusion 100mg

HYDRINE Capsule 500mg (Hydroxyurea 500mg)

Uromes Injection 100mg/ml

DTI FOR INJECTION

UNITAXEL Inj. 100mg/16.67mL Concentrate for Solution for Infusion

VINRACINE INJECTION 1MG/1ML

Pemirex powder for concentrate for solution for infusion 500mg

DAUNOCIN FOR INJ

MITONCO 10mg powder for solution for injection/infusion or intravesical

News

No news articles found

On this page

Overview
Clinical Trials24
Approvals63
News

Back to Organizations